LIVING THE LAB LIFE
A BLOG FOR ASCLS REGION V
ASCLS Education and Research Fund awards grants, awards, and scholarships to deserving students of laboratory science. Graduate and undergraduate awards are available, but only if you apply.
Alpha Mu Tau undergraduate and graduate scholarships are due March 15th, 2017.
For the Gloria F. "Mike" Gilbert Memorial award, which recognizes excellence in management, applications due April 1st, 2017 to Executive VP Jim Flanigan.
Two research grants (The Member Grant, Dean Spradling Research Grant) applications are due to Executive VP Jim Flanigan by May 1st, 2017 at 11:59PM EST.
Check out the latest #IamASCLS member spotlight, featuring ASCLS-SD Student member Kyle Kaiwusaier. Kyle is an intern at Sioux Falls Avera McKennan hospital who is originally from China. Find out about what Kyle loves about Medical Laboratory Science and ASCLS.
ASCLS-ND is seeking nominations for several opening positions. Nominate a deserving member or nominate yourself for an opportunity to become involved in ASCLS-ND! Nominations will be accepted until Friday March 10th, 2017. Please include the name of the person and either their: email, phone number, or place of employment. A list of current ASCLS members is attached. Submit nominations by email to email@example.com
Nominations are needed for the following positions (a full job description of each position may be found at www.asclsnd.org/bylaws.htm)
President-elect: 1 year term, advance to President the following year
Nominations Committee Chair: 1 year term
New Professional Delegate (must be a person in the field for < 5 years): 1 year term
Delegate: 1 year term
Board Member at Large: 2 year term
Attention all laboratorians, please share this message with all your friends who work/live in North Dakota:
It has been brought to my attention that there is an URGENT matter (or in lab language...STAT!) related to laboratory testing in our state. Right now, there is a bill being debated in the ND Legislature, related to who can perform laboratory testing. The wording proposed would allow anyone to perform waived testing anywhere, without supervision.
Please read the attached letter ("Bill 2202") prepared by ASCLS-ND Past-President Alice Hawley, which describes the situation AND provides you an opportunity to become involved in making sure this dangerous legislation is not passed. Please read it immediately, as action is needed as soon as tomorrow. This is a great opportunity to have a Voice in shaping our profession - thank you in advance for any and all attention to this matter!
Brooke Solberg, PhD, MLS(ASCP)CM
Associate Professor – Department of Medical Laboratory Science
UND School of Medicine and Health Sciences
Here is an interesting case that we saw in our blood bank recently:
An obstetric patient came to the laboratory to be drawn for a Type and Screen. She was scheduled for an elective cesarean section the next day, at thirty-eight weeks gestation.
Our initial results (in gel card):
ABORH: O negative
Since the patient was new to our blood bank, we performed a full antibody identification panel. Patient had 3+ reactivity on all D-positive cells. Additionally, she had 2+ reactivity on the D-negative, C-positive cell in the panel. This seemed to suggest that patient had an anti-D and anti-C; we had yet to determine whether the anti-D was active or passive (due to RhIg administration). We could not call to find out about past RhIg therapy, since the patient had been drawn as an outpatient and was no longer on site. Additionally, we could not contact her primary care provider, as it was late in the evening and the clinics were closed.
As per standard procedure, we contacted another local hospital blood bank where the patient had been seen for her prenatal work. That blood bank had identified anti-D, but did not have record of whether the anti-D was active or passive.
We sent out the patient’s specimen to our reference blood bank for antibody identification and titer results. The anti-D titer came out to 1:64 (a passive anti-D does not typically titer this high, so this suggests the anti-D is active). The reference lab also identified an anti-G, not an anti-C. The anti-G titer result was null.
Anti-G is one of the lesser-known antigens in the Rh system. It is present on all C-antigen positive cells and most D-antigen positive cells. For this reason, the anti-G antibody can look like anti-D and anti-C in patient testing. For transfusion purposes, it is not necessary to distinguish between anti-G or anti-D,-C, since any cells that are D-antigen and C-antigen negative will also be G-antigen negative. However, it is important to accurately identify anti-G in obstetric patients. Obstetric patients with anti-G are candidates for RhIg, whereas a patient with active anti-D is not. A blood bank reference laboratory can perform elution and adsorption studies to distinguish between anti-G and anti-D,-C. In this case of our patient, since she has both an active anti-D and anti-G, she is not a candidate for RhIg (we later confirmed with the patient’s care team that she had not received RhIg and it fact had been alloimmunized to the D-antigen years before).
Harmening, D. M. (2012). Modern Blood Banking & Transfusion Practices (6th ed.). Philadelphia: F.A. Davis.
Don't miss out on the ASCLS-WI Annual State Meeting, April 3-5th, 2017.
Marriot Madison West